Similarly, Circ-NOL10 could suppress breast cancer carcinogenesis by upregulating PDCD4 via a circ-NOL10/miR-149-5p/miR-330-3p/miR-452-5p/PDCD4 pathway (64). Here, PDCD4 is linked to breast cancer.